Kinaxis Inc (TSE:KXS) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $147.08 and traded as high as $176.35. Kinaxis shares last traded at $173.65, with a volume of 89,866 shares.
A number of research firms have recently issued reports on KXS. Scotiabank lifted their price objective on shares of Kinaxis to C$140.00 in a research note on Wednesday, April 29th. National Bank Financial lifted their price target on shares of Kinaxis from C$150.00 to C$200.00 and gave the stock an “outperform” rating in a research note on Friday, May 8th. TD Securities upped their price objective on shares of Kinaxis from C$165.00 to C$190.00 in a research report on Monday, May 11th. Royal Bank of Canada raised their target price on Kinaxis from C$140.00 to C$175.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Finally, Canaccord Genuity boosted their price target on Kinaxis from C$125.00 to C$190.00 in a research note on Friday, May 8th. Five investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus target price of C$161.44.
The company has a market cap of $4.57 billion and a P/E ratio of 214.14. The company’s 50-day moving average price is C$148.52 and its two-hundred day moving average price is C$117.26. The company has a current ratio of 2.91, a quick ratio of 2.83 and a debt-to-equity ratio of 3.37.
Kinaxis Company Profile (TSE:KXS)
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. The company offers RapidResponse, which provide supply chain planning and analytics capabilities for managing various supply chain management processes, including demand planning, supply planning, inventory management, order fulfillment, capacity planning, and master scheduling, as well as sales and operations planning process.
Featured Story: Trading Strategy
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.